Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Nov 15, 2022
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The overarching goal of this study is to test the impact of a precision risk feedback tool aiming to address gaps in clinician and patient uptake of lung cancer screening and tobacco treatment. This study builds on evidence that (1) clinical and genetic factors may inform precision risk on lung cancer and smoking cessation and (2) increasingly high demand for personal genetic risk in particular may signal its potential to activate behavior change. The multi-level precision prevention intervention to be tested--RiskProfile-- provides the opportunity to present personalized clinical and genet...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- CLINICIANS:
- • - Primary care clinician with active caseload in participating clinics
- PATIENTS:
- • Patient of participating primary care clinician
- • Lung cancer screening naïve
- • Between 50 to 80 years of age, inclusive
- • Current or former smokers
- • Pack years ≥ 20
- • English-speaking
- Exclusion Criteria:
- PATIENTS:
- • Lung cancer diagnosis
- • Current order placed for lung cancer screening
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Alex Ramsey, Ph.D.
Principal Investigator
Washington University School of Medicine
Li-Shiun Chen, M.D., MPH, ScD
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials